JPRN-jRCT2031220193招募中未知
Prospective, Post Marketing Surveillance of CAROGRA Tablets
Arai Yuki0 个研究点目标入组 300 人开始时间: 2022年7月8日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Moderate ulcerative colitis (limited to those patients who had inadequate response to 5-aminosalicylic acid)
排除标准
- 未提供
研究者
相似试验
已完成
Unknown
Prospective, Post Marketing Surveillance of GOOFICEChronic constipationJPRN-jRCT1080223950EA Pharma Co.,Ltd.3,000
招募中
4 期
Evaluation of AryoTrust administration in treatment of breast cancerIRCT20150303021315N16Aryogen597
尚未招募
4 期
A post-marketing surveillance for the Evaluation of the safety of TGlobulin25 for the induction of immunosuppressive therapy in adult kidney transplant candidatesIRCT20201230049888N1Kawsar biotech company100
进行中（未招募）
不适用
reactogenicity and safety of Vaxem™HibMeningitis, epiglottitis, pneumonia, arthritis caused by Haemophilus influenzae type b.EUCTR2014-005203-24-Outside-EU/EEAovartis Vaccines and Diagnostics750
招募中
4 期
A post marketing study to evaluate safety and effectiveness of Remogliflozin and Remogliflozin-Metformin Combination in treatment of Diabetes patientsCTRI/2019/11/022062Glenmark Pharmaceuticals Ltd